A nomogram based on serum cystatin C for predicting acute kidney injury in patients with traumatic brain injury

References

• Dewan MC, Rattani A, Gupta S, et al. Estimating the global incidence of traumatic brain injury. J Neurosurg. 2018;130(4):1080–1097.
   PubMed Web of Science ®Google Scholar
• Zygun DA, Kortbeek JB, Fick GH, et al. Non-neurologic organ dysfunction in severe traumatic brain injury. Crit Care Med. 2005;33(3):654–660.
   PubMed Web of Science ®Google Scholar
• Zygun D. Non-neurological organ dysfunction in neurocritical care: impact on outcome and etiological considerations. Curr Opin Crit Care. 2005;11(2):139–143.
   PubMed Web of Science ®Google Scholar
• Moore EM, Bellomo R, Nichol A, et al. The incidence of acute kidney injury in patients with traumatic brain injury. Renal Failure. 2010;32(9):1060–1065.
   PubMed Web of Science ®Google Scholar
• Li N, Zhao WG, Zhang WF. Acute kidney injury in patients with severe traumatic brain injury: implementation of the acute kidney injury network stage system. Neurocrit Care. 2011;14(3):377–381.
   PubMed Web of Science ®Google Scholar
• Skrifvars MB, Moore E, Martensson J, et al.; The EPO-TBI Investigators and the ANZICS Clinical Trials Group. Erythropoietin in traumatic brain injury associated acute kidney injury: A randomized controlled trial. Acta Anaesthesiol Scand. 2019;63(2):200–207.
   PubMed Web of Science ®Google Scholar
• Corral L, Javierre CF, Ventura JL, et al. Impact of non-neurological complications in severe traumatic brain injury outcome. Crit Care. 2012;16(2):R44.
   PubMed Web of Science ®Google Scholar
• Sadan O, Singbartl K, Kraft J, et al. Low-chloride- versus high-chloride-containing hypertonic solution for the treatment of subarachnoid hemorrhage-related complications: The ACETatE (A low ChloriE hyperTonic solution for brain Edema) randomized trial. J Intensive Care. 2020;8(1):32.
   PubMed Web of Science ®Google Scholar
• Büttner S, Stadler A, Mayer C, et al. Incidence, risk factors, and outcome of acute kidney injury in neurocritical care. J Intensive Care Med. 2020;35(4):338–346.
   PubMed Web of Science ®Google Scholar
• An S, Luo H, Wang J, et al. An acute kidney injury prediction nomogram based on neurosurgical intensive care unit profiles. Ann Transl Med. 2020;8(5):194–194.
   PubMed Web of Science ®Google Scholar
• Deng Y, Yuan J, Chi R, et al. The incidence, risk factors and outcomes of postoperative acute kidney injury in neurosurgical critically Ill patients. Sci Rep. 2017;7(1):4245.
   PubMedGoogle Scholar
• Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40(2):221–226.
   PubMed Web of Science ®Google Scholar
• Odutayo A, Cherney D. Cystatin C and acute changes in glomerular filtration rate. Clin Nephrol. 2012;78(1):64–75.
   PubMed Web of Science ®Google Scholar
• Sjöström P, Tidman M, Jones I. The shorter T1/2 of cystatin C explains the earlier change of its serum level compared to serum creatinine. Clin Nephrol. 2004;62(3):241–242.
   PubMed Web of Science ®Google Scholar
• Nguyen MT, Devarajan P. Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol. 2008;23(12):2151–2157.
   PubMed Web of Science ®Google Scholar
• Coll E, Botey A, Alvarez L, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000;36(1):29–34.
   PubMed Web of Science ®Google Scholar
• Nejat M, Pickering JW, Walker RJ, et al. Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit. Nephrol Dialysis Transplantation. 2010;25(10):3283–3289.
   PubMed Web of Science ®Google Scholar
• Swaminathan M, Phillips-Bute BG, Conlon PJ, et al. The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. Ann Thorac Surg. 2003;76(3):784–791.
   PubMed Web of Science ®Google Scholar
• Deng Y, Chi R, Chen S, et al. Evaluation of clinically available renal biomarkers in critically ill adults: a prospective multicenter observational study. Crit Care. 2017;21(1):46.
   PubMedGoogle Scholar
• Rickli H, Benou K, Ammann P, et al. Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media. Clin Nephrol. 2004;61(2):98–102.
   PubMed Web of Science ®Google Scholar
• Delanaye P, Lambermont B, Chapelle JP, et al. Plasmatic cystatin C for the estimation of glomerular filtration rate in intensive care units. Intensive Care Medicine. 2004;30(5):980–983.
   PubMed Web of Science ®Google Scholar
• El-Sadek AE, El-Gamasy MA, Behiry EG, et al. Plasma cystatin C versus renal resistive index as early predictors of acute kidney injury in critically ill neonates. J Pediatr Urol. 2020;16(2):206.e1–e201-206.e208.
   Web of Science ®Google Scholar
• Wang X, Lin X, Xie B, et al. Early serum cystatin C-enhanced risk prediction for acute kidney injury post cardiac surgery: a prospective, observational, cohort study. Biomarkers. 2020;25(1):20–26.
   PubMed Web of Science ®Google Scholar
• Krawczeski CD, Vandevoorde RG, Kathman T, et al. Serum cystatin C is an early predictive biomarker of acute kidney injury after pediatric cardiopulmonary bypass. CJASN. 2010;5(9):1552–1557.
   PubMed Web of Science ®Google Scholar
• Zappitelli M, Greenberg JH, Coca SG, et al.; Translational Research Investigating Biomarker Endpoints in Acute Kidney Injury (TRIBE-AKI) Consortium. Association of definition of acute kidney injury by cystatin C rise with biomarkers and clinical outcomes in children undergoing cardiac surgery. JAMA Pediatr. 2015;169(6):583–591.
   PubMed Web of Science ®Google Scholar
• Lim HB, Smith M. Systemic complications after head injury: a clinical review. Anaesthesia. 2007;62(5):474–482.
   PubMed Web of Science ®Google Scholar
• Dudoignon E, Moreno N, Deniau B, et al. Activation of the renin-angiotensin-aldosterone system is associated with Acute Kidney Injury in COVID-19. Anaesth Crit Care Pain Med. 2020;39(4):453–455.
   PubMed Web of Science ®Google Scholar
• Chen YT, Chan CK, Li WY, et al. Renin-angiotensin-aldosterone system inhibition decreased contrast-associated acute kidney injury in chronic kidney disease patients. J Formosan Med Assoc Taiwan yi Zhi. 2021;120(1):641–650.
   PubMed Web of Science ®Google Scholar
• Giannoudis PV, Harwood PJ, Loughenbury P, Van Griensven M, et al. Correlation between IL-6 levels and the systemic inflammatory response score: can an IL-6 cutoff predict a SIRS state? J Trauma. 2008;65(3):646–652.
   PubMedGoogle Scholar
• Staubli SM, Schäfer J, Rosenthal R, et al. The role of CRP and Pentraxin 3 in the prediction of systemic inflammatory response syndrome and death in acute pancreatitis. Sci Rep. 2019;9(1):18340.
   PubMedGoogle Scholar
• Zhang WR, Garg AX, Coca SG, TRIBE-AKI Consortium, et al. Plasma IL-6 and IL-10 concentrations predict AKI and long-term mortality in adults after cardiac surgery. J Am Soc Nephrol. 2015;26(12):3123–3132.
   PubMed Web of Science ®Google Scholar
• Maiwall R, Chandel SS, Wani Z, et al. SIRS at admission is a predictor of AKI development and mortality in hospitalized patients with severe alcoholic hepatitis. Dig Dis Sci. 2016;61(3):920–929.
   PubMed Web of Science ®Google Scholar
• Yang BH, He Q, Ding CY, et al. High-sensitivity C-reactive protein as a predictive factor of acute kidney injury following aneurysmal subarachnoid hemorrhage: a prospective observational study. Acta Neurochir (Wien). 2019;161(9):1783–1791.
   PubMed Web of Science ®Google Scholar
• Bouma HR, Ploeg RJ, Schuurs TA. Signal transduction pathways involved in brain death-induced renal injury. Am J Transplant. 2009;9(5):989–997.
   PubMed Web of Science ®Google Scholar
• Seo YS, Park SY, Kim MY, et al. Serum cystatin C level: An excellent predictor of mortality in patients with cirrhotic ascites. J Gastroenterol Hepatol. 2018;33(4):910–917.
   PubMed Web of Science ®Google Scholar
• Hendrickson CM, Kwong YD, Belzer AG, et al. Higher plasma cystatin C is associated with mortality after acute respiratory distress syndrome: findings from a Fluid and Catheter Treatment Trial (FACTT) substudy. Crit Care. 2020;24(1):416.
   PubMed Web of Science ®Google Scholar
• Bell M, Granath F, Mårtensson J, et al.; KING (Karolinska Intensive care Nephrology Group). Cystatin C is correlated with mortality in patients with and without acute kidney injury. Nephrol Dial Transplant. 2009;24(10):3096–3102.
   PubMed Web of Science ®Google Scholar
• Angeli F, Verdecchia P, Savonitto S, et al. Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the. Eur Soc Cardiol. 2015;11(8):757–764.
   Google Scholar
• Shlipak MG, Katz R, Fried LF, et al. Cystatin-C and mortality in elderly persons with heart failure. J Am Coll Cardiol. 2005;45(2):268–271.
   PubMed Web of Science ®Google Scholar
• Volpon LC, Sugo EK, Carlotti AP. Diagnostic and prognostic value of serum cystatin C in critically ill children with acute kidney injury. Pediatric Crit Care Med. 2015;16(5):e125-131.
   Web of Science ®Google Scholar
• Luo J, Wang LP, Hu HF, et al. Cystatin C and cardiovascular or all-cause mortality risk in the general population: A meta-analysis. Clin Chim Acta Inter J Clin Chem. 2015;450:39–45.
   PubMed Web of Science ®Google Scholar
• Shi J, Zhang C, Cao Y, et al. Prognostic value of cystatin C in acute ischemic stroke patients with intravenous thrombolysis. CNR. 2019;16(4):301–309.
   Google Scholar
• Zhang JB, Jü XH, Wang J, et al. Serum cystatin C and cerebral microbleeds in patients with acute cerebral stroke. J Clin Neurosci. 2014;21(2):268–273.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Zhong C, Xu T, et al. Prognostic significance of serum cystatin C in acute ischemic stroke patients according to lipid component levels. Atherosclerosis. 2018;274:146–151.
   PubMed Web of Science ®Google Scholar
• Goksu E, Goksu E, Karsli B, et al. Cerebrospinal fluid cystatin C levels following treatment for aneurysmal subarachnoid hemorrhage. Turk Neurosurg. 2014;24(3):391–397.
   PubMed Web of Science ®Google Scholar
• Zeng Q, Lin K, Yao M, et al. Significant correlation between cystatin C, cerebral infarction, and potential biomarker for increased risk of stroke. CNR. 2015;12(1):40–46.
   Google Scholar
• Hanrieder J, Wetterhall M, Enblad P, et al. Temporally resolved differential proteomic analysis of human ventricular CSF for monitoring traumatic brain injury biomarker candidates. J Neurosci Methods. 2009;177(2):469–478.
   PubMed Web of Science ®Google Scholar
• Zhang J, Ding R, Xian Q, et al. Serum cystatin C is increased in acute spinal cord injury: a multicentre retrospective study. Spinal Cord. 2020;58(3):341–347.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li J, Wang Z, et al. Attenuation of early brain injury and learning deficits following experimental subarachnoid hemorrhage secondary to Cystatin C: possible involvement of the autophagy pathway. Mol Neurobiol. 2014;49(2):1043–1054.
   PubMed Web of Science ®Google Scholar
• Liu Y, Cai H, Wang Z, et al. Induction of autophagy by cystatin C: a potential mechanism for prevention of cerebral vasospasm after experimental subarachnoid hemorrhage. Eur J Med Res. 2013;18(1):21.
   PubMedGoogle Scholar
• Yang B, Xu J, Chang L, et al. Cystatin C improves blood-brain barrier integrity after ischemic brain injury in mice. J Neurochem. 2020;153(3):413–425.
   PubMed Web of Science ®Google Scholar
• Lassnigg A, Schmidlin D, Mouhieddine M, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;15(6):1597–1605.
   PubMed Web of Science ®Google Scholar
• Herget-Rosenthal S, Marggraf G, Hüsing J, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int. 2004;66(3):1115–1122.
   PubMed Web of Science ®Google Scholar
• Weller S, Varrier M, Ostermann M. Lymphocyte function in human acute kidney injury. Nephron. 2017;137(4):287–293.
   PubMed Web of Science ®Google Scholar
• Inaba A, Tuong ZK, Riding AM, et al. B lymphocyte-derived CCL7 augments neutrophil and monocyte recruitment, exacerbating acute kidney injury. J Immunol. 2020;205(5):1376–1384.
   PubMed Web of Science ®Google Scholar
• Zheng L, Gao W, Hu C, et al. Immune cells in ischemic acute kidney injury. Curr Protein Pept Sci. 2019;20(8):770–776.
   PubMed Web of Science ®Google Scholar
• Zheng CF, Liu WY, Zeng FF, et al. Prognostic value of platelet-to-lymphocyte ratios among critically ill patients with acute kidney injury. Crit Care. 2017;21(1):238.
   PubMedGoogle Scholar
• Gameiro J, Lopes JA. Complete blood count in acute kidney injury prediction: a narrative review. Ann Intensive Care. 2019;9(1):87.
   PubMed Web of Science ®Google Scholar
• Bu X, Zhang L, Chen P, et al. Relation of neutrophil-to-lymphocyte ratio to acute kidney injury in patients with sepsis and septic shock: A retrospective study. Int Immunopharmacol. 2019;70:372–377.
   PubMed Web of Science ®Google Scholar
• Bi JB, Zhang J, Ren YF, et al. Neutrophil-to-lymphocyte ratio predicts acute kidney injury occurrence after gastrointestinal and hepatobiliary surgery. World J Gastrointest Surg. 2020;12(7):326–335.
   PubMed Web of Science ®Google Scholar
• Karkouti K, Grocott HP, Hall R, et al. Interrelationship of preoperative anemia, intraoperative anemia, and red blood cell transfusion as potentially modifiable risk factors for acute kidney injury in cardiac surgery: a historical multicentre cohort study. Can J Anesth. 2015;62(4):377–384.
   PubMed Web of Science ®Google Scholar
• Karkouti K, Wijeysundera DN, Yau TM, et al. Influence of erythrocyte transfusion on the risk of acute kidney injury after cardiac surgery differs in anemic and nonanemic patients. Anesthesiology. 2011;115(3):523–530.
   PubMed Web of Science ®Google Scholar
• Maaranen P, Husso A, Tauriainen T, et al. Blood transfusion and outcome after transfemoral transcatheter aortic valve replacement. J Cardiothoracic Vasc Anesthesia. 2019;33(11):2949–2959.
   PubMed Web of Science ®Google Scholar
• Nilsson CU, Bentzer P, Andersson LE, et al. Mortality and morbidity of low-grade red blood cell transfusions in septic patients: a propensity score-matched observational study of a liberal transfusion strategy. Ann Intensive Care. 2020;10(1):111.
   PubMed Web of Science ®Google Scholar
• Chowdhury AH, Cox EF, Francis ST, et al. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-Lyte® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012;256(1):18–24.
   PubMed Web of Science ®Google Scholar
• Kumar AB, Shi Y, Shotwell MS, et al. Hypernatremia is a significant risk factor for acute kidney injury after subarachnoid hemorrhage: a retrospective analysis. Neurocrit Care. 2015;22(2):184–191.
   PubMed Web of Science ®Google Scholar
• Sigmon J, May CC, Bryant A, et al. Assessment of acute kidney injury in neurologically injured patients receiving hypertonic sodium chloride: does chloride load matter? Ann Pharmacother. 2020;54(6):541–546.
   PubMed Web of Science ®Google Scholar
• Jiang S, Shen Y, Zhao X. Hyperchloremia is associated with acute kidney injury in patients with aneurysmal subarachnoid hemorrhage: not sure. Crit Care Med. 2017;45(10):e1099.
   PubMed Web of Science ®Google Scholar
• Yamane DP, Maghami S, Graham A, et al. Association of hyperchloremia and acute kidney injury in patients with traumatic brain injury. J Intens Care Med. 2020:885066620978735.
   PubMed Web of Science ®Google Scholar